Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Evaluation of an Online Peri-operative Health Education Platform for Patients Undergoing Spine Surgery: Ready Set Recover

10 de agosto de 2026 atualizado por: Dharma Colgan, National University of Natural Medicine

Chronic back pain is the world's leading cause of disability, with spine surgery being a common yet costly intervention. However, many patients experience suboptimal recovery, with persistent pain and functional limitations contributing to high healthcare utilization and costs. Traditional surgical pathways often overlook the role of mental well-being and patient engagement in recovery. However, research indicates that interventions promoting self-management and stress reduction can lead to improvements in pain, faster recovery, and reduced hospital readmissions.

Evidence shows that preoperative psychosocial factors, such as anxiety and depression, significantly predict post-surgical outcomes, yet structured perioperative support is lacking. To address this gap, Ready Set Recover (RSR), a mobile health (mHealth) intervention, provides education, behavioral strategies, and psychosocial support to enhance surgical preparedness and optimize post-surgical recovery. By addressing both psychological and behavioral factors, RSR has the potential to fill a critical gap in perioperative care. As a scalable digital platform, RSR offers an accessible, cost-effective solution that can be easily integrated into existing surgical care models, reducing the burden on healthcare providers while empowering patients to take an active role in their healing process.

RSR aims to accomplish this by integrating evidence-based components such as cognitive behavioral therapy, mindfulness, gratitude practices, and guided movement to foster patient empowerment and sustainable health practices in the pre- and post-surgical periods. The platform provides patients with a structured and flexible tool to improve self-efficacy, adherence to post-surgical recommendations, and the overall surgical recovery experience.

This study aims to evaluate the feasibility and acceptability of RSR through an explanatory mixed-methods pilot randomized controlled trial (RCT) in patients undergoing medium-to-long segment spinal fusion at Oregon Health & Science University.

Aim 1 assesses feasibility and acceptability by measuring patient engagement, intervention completion rates, and satisfaction.

Aim 2 qualitatively evaluate barriers and facilitators to implementation of RSR within the clinic setting via provider, patient, and clinic stakeholder semi-structured interviews.

Aim 3 establishes a patient community advisory board (CAB) to guide future research and the development of a Phase II Small Business Technology Transfer (STTR) efficacy trial.

Findings from this study will inform the refinement and scalability of RSR as a low-burden, cost-effective solution to improve surgical outcomes. Insights gained from this research may extend beyond spine surgery, informing the development of digital health interventions for other surgical populations, ultimately advancing patient-centered, technology-driven approaches to perioperative care.

Visão geral do estudo

Tipo de estudo

Intervencional

Inscrição (Estimado)

60

Estágio

  • Fase inicial 1

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

  • Nome: Ryan Wexler Assistant Research Investigator, ND, MSRC
  • Número de telefone: 15034947377
  • E-mail: rwexler@nunm.edu

Estude backup de contato

  • Nome: Dana Dharmakaya Colgan Assistant Professor, PhD
  • Número de telefone: 5034947377
  • E-mail: dcolgan@nunm.edu

Locais de estudo

    • Oregon
      • Portland, Oregon, Estados Unidos, 97201
        • Oregon Health & Science University
        • Contato:
          • Dana Dharmakaya Colgan Assistant Professor, PhD
          • Número de telefone: 15034947377
          • E-mail: colgand@ohsu.edu
        • Contato:
          • Ryan Wexler, ND, MSCR
          • Número de telefone: 5034947377
          • E-mail: rwexler@nunm.edu

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Não

Descrição

Inclusion Criteria:

  • Patients deemed candidates for medium-/long-segment spinal fusion
  • Patients who score a > 4 on a 0-10 NRS for the question "How motivated are you to participate in this research study?"
  • At least 18 years of age and not older than 80 at the time of study enrollment •Ability to read and understand English
  • Daily access to the internet via cell phone, tablet, or computer

Exclusion Criteria:

  • Have received epidural steroid injection for low back pain, lumbosacral radiculopathy, or scoliosis in the prior 3 months
  • Have received a surgical intervention for low back pain, lumbosacral radiculopathy, or scoliosis in the previous 6 months
  • Concurrent diagnosis of cancer
  • Cognitive impairment
  • Severe comorbidities (e.g., terminal illness, severe organ failure)
  • Non-elective/emergency surgery in the past

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Outro
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Sem intervenção: Surgery + Standard of Care
Surgery + Standard of care is defined as instrumented spinal fusion with routine perioperative care, including preoperative information, postoperative mobilization, and standard analgesia.
Experimental: Surgery+RSR
Spinal Fusion + Ready Set Recover. Ready Set Recover is a peri-operative mHealth platform designed to help patients prepare for and recover from surgery. RSR empowers patients to be a self-advocate in their surgical journey, plan appropriately for surgery day, garner support from loved ones, and maintain healthy lifestyle practices including: spending time in nature, mindfulness practices and stress reduction, gratitude practice, and post-surgical mindful movement. These activities encourage intrinsically motivated, sustainable behavior change that supports surgical recovery.
Ready Set Recover is a peri-operative mHealth platform designed to help patients prepare for and recover from surgery. RSR empowers patients to be a self-advocate in their surgical journey, plan appropriately for surgery day, garner support from loved ones, and maintain healthy lifestyle practices including: spending time in nature, mindfulness practices and stress reduction, gratitude practice, and post-surgical mindful movement. These activities encourage intrinsically motivated, sustainable behavior change that supports surgical recovery.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Feasibility of Retention
Prazo: 30 days post-surgery
Measured using a participant tracking spreadsheet
30 days post-surgery
Adverse Events (AEs)
Prazo: Daily from baseline through end of intervention (30 days post surgery)
The study team will regularly monitor for adverse events via the daily survey. In addition to reporting adverse events to the IRB, the investigators will regularly review adverse events at each study meeting in order to rapidly address these events and to facilitate early recognition of any emerging patterns.
Daily from baseline through end of intervention (30 days post surgery)
Feasibility of enrollment
Prazo: Data collected during screening and enrollment process
Enrollment Rate: Measured using a participant tracking spreadsheet.
Data collected during screening and enrollment process
Feasibility of Adherence
Prazo: Daily from baseline through end of intervention (30 days post surgery)
Measured through completion with the RSR daily actions and educational materials.
Daily from baseline through end of intervention (30 days post surgery)
Acceptability and Accessibility
Prazo: 30- days post surgery
Measured through the qualitative study exit interview and the Client Satisfaction Questionnaire.
30- days post surgery

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Visual Analog Scale for Pain Back Pain Intensity
Prazo: Daily from baseline through end of intervention (30 days post surgery)
The NRS is a self-reported scale where participants will be asked to report their pain intensity on a scale from 0 to 10 (0 = "no pain", 10 = "worst pain").
Daily from baseline through end of intervention (30 days post surgery)
Modified Oswestry Disability Index (ODI)
Prazo: 30 Days Pre-surgery and 30 Days Post-surgery
Designed to assess the impact of pain on participants' ability to perform activities of daily living such as personal care, lifting, walking, and sitting. 0 to 100% (raw 0-50 points), with lower scores indicating better function.
30 Days Pre-surgery and 30 Days Post-surgery
Central Sensitization Inventory (CSI)
Prazo: 30 Days Pre-surgery and 30 Days Post-surgery
Participants' pain experiences specifically related to hypersensitivity and allodynia to discern whether an individual may experience central sensitization. Scores range from 0 to 100, with higher scores indicating greater central sensitization-related symptom burden.
30 Days Pre-surgery and 30 Days Post-surgery
Tampa Scale of Kinesiophobia
Prazo: 30 Days Pre-surgery and 30 Days Post-surgery
The TSK-11 is designed to assess for the presence of fear of movement. Scores range from 11-44 (11 items, 4-point Likert 1 = strongly disagree to 4 = strongly agree). Higher scores indicate greater fear of movement/(re)injury
30 Days Pre-surgery and 30 Days Post-surgery
Pain Catastrophizing Scale (PCS)
Prazo: 30 Days Pre-surgery and 30 Days Post-surgery
The PCS is ubiquitously used to assess pain catastrophizing via its subscales: helplessness, rumination, and magnification. Scores range from 0-52 (13 items, each 0 = not at all to 4 = all the time). Higher = greater catastrophizing.
30 Days Pre-surgery and 30 Days Post-surgery
Pain Self-efficacy Questionnaire (PSEQ)
Prazo: 30 Days Pre-surgery and 30 Days Post-surgery
The PSEQ is designed to assess participants perceived ability and confidence to manage their pain. Scores range from 0-60 (10 items, 0 = not at all confident to 6 = completely confident). Higher scores indicate greater pain self-efficacy.
30 Days Pre-surgery and 30 Days Post-surgery
PROMIS Ability to Participate in Social Roles
Prazo: 30 Days Pre-surgery and 30 Days Post-surgery
The ability to participate in social roles questionnaire is a PROMIS measure designed to evaluate the impact of a condition on social engagement. It uses a T-score metric, mean 50 ± 10 (US general population); practical range ~20-80 . Higher scores indicate better social participation; <40 = moderate-severe impairment.
30 Days Pre-surgery and 30 Days Post-surgery
Brief Pain Inventory (BPI)
Prazo: 30 Days Pre-surgery and 30 Days Post-surgery
The BPI has previously been used to assess pain interference in patients with chronic pain and is the most frequently used measure of pain interference in trials of MORE. Scores range from 0-10 (mean of 7 items). Higher scores indicate worse interference; MCID ≥1-point improvement.
30 Days Pre-surgery and 30 Days Post-surgery
Patients' Endorsement of a Biopsychosocial Model of Chronic Pain Scale (PEB):
Prazo: 30 Days Pre-surgery and 30 Days Post-surgery
The PEB is designed to assess patients' beliefs about the biopsychosocial model of chronic pain. Includes 11 items, unidimensional. Higher scores indicate greater endorsement of a biopsychosocial pain model, associated with greater readiness for/engagement in self-management.
30 Days Pre-surgery and 30 Days Post-surgery
Patient Reported Outcomes Measurement Information System (PROMIS)-29:
Prazo: 30 Days Pre-surgery and 30 Days Post-surgery

The PROMIS- 29 assesses an individual's overall quality of life using self-reporting questions in domains such as physical function, anxiety, depression, fatigue, sleep disturbance. Each of 7 domains scored as a T-score, mean 50 ± 10; plus single 0-10 pain intensity item Direction is domain-dependent. Higher scores indicate better physical function and ability to participate in social roles and activities.

Lower scores are better in anxiety, depression, fatigue, sleep disturbance, pain interference subscales.

30 Days Pre-surgery and 30 Days Post-surgery
Perioperative Anxiety Scale-7 (PAS-7)
Prazo: 30 Days Pre-surgery and 30 Days Post-surgery
The peri-operative anxiety scale was developed in collaboration with psychiatrists, anesthesiologists, and surgeons to assess mental and somatic symptoms of pre-operative anxiety.
30 Days Pre-surgery and 30 Days Post-surgery
Generalized Anxiety Disorder (GAD)-7
Prazo: 30 Days Pre-surgery and 30 Days Post-surgery
The GAD-7 is a screening tool used for assessing symptoms of generalized anxiety disorder. Scores range from 0-21 (7 items, 0 = not at all to 3 = nearly every day). Higher indicates greater anxiety severity.
30 Days Pre-surgery and 30 Days Post-surgery
Multidimensional Assessment of Interoceptive Awareness - Version 2 (MAIA-2)
Prazo: 30 Days Pre-surgery and 30 Days Post-surgery
MAIA-2 is designed as a tool to assess interoceptive awareness. It is made up of eight subscales including: noticing, not-distracting, not-worrying, attention regulation, emotional awareness, self-regulation, body listening, and trust. Each subscale is totaled separately. Subscales are scored 0-5 (mean of items). Higher scores indicate greater interoceptive awareness.
30 Days Pre-surgery and 30 Days Post-surgery

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

30 de setembro de 2026

Conclusão Primária (Estimado)

30 de setembro de 2027

Conclusão do estudo (Estimado)

30 de setembro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

4 de agosto de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

10 de agosto de 2026

Primeira postagem (Real)

17 de agosto de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

17 de agosto de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

10 de agosto de 2026

Última verificação

1 de agosto de 2026

Mais Informações

Termos relacionados a este estudo

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever